NCT00070382
- Conditions
- Amyloidosis, Anemia, Blood Protein Disorders, +55 more
- Locations
-
- Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States
Clinical trial condition
Sezary Syndrome
Explore clinical trials studying Sezary Syndrome. Study availability and eligibility vary by location and protocol.
262 public trials
17 recruiting studies
Sezary Syndrome trial results
NCT00068523
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +68 more
- Locations
-
- Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT00750009
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +106 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
- Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States
NCT00003687
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +93 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada
- Newfoundland Cancer Treatment and Research Foundation St. John's, Newfoundland and Labrador, Canada
- Princess Margaret Hospital Toronto, Ontario, Canada
- McGill University Montreal, Quebec, Canada
NCT00918333
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +75 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mark O Hatfield-Warren Grant Magnuson Clinical Center Bethesda, Maryland, United States
- Mayo Clinic Rochester, Minnesota, United States
NCT01094860
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +39 more
- Locations
-
- University of Texas MD Anderson Cancer Center Houston, Texas, United States
NCT00040846
- Conditions
- Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), +164 more
- Locations
-
- Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
- LDS Hospital Salt Lake City, Utah, United States
- VA Puget Sound Health Care System Seattle, Washington, United States
- Conditions
- Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +250 more
- Locations
-
- Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
- LDS Hospital Salt Lake City, Utah, United States
- VA Puget Sound Health Care System Seattle, Washington, United States
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00014235
- Conditions
- Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, +159 more
- Locations
-
- University of Arizona Health Sciences Center Tucson, Arizona, United States
- City of Hope Medical Center Duarte, California, United States
- Stanford University Hospitals and Clinics Stanford, California, United States
- OHSU Knight Cancer Institute Portland, Oregon, United States
- Conditions
- Acute Undifferentiated Leukemia, Adenocarcinoma, Adult Nasal Type Extranodal NK/T-cell Lymphoma, +152 more
- Locations
-
- Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
- University of Torino Torino, Italy